Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hemophilia
Biotech
ASH: Pfizer swims in crowded sickle cell, hemophilia waters
Novo Nordisk and Pfizer are not going head-to-head in hemophilia. But they are, at least, racing side-by-side.
Annalee Armstrong
Dec 9, 2023 7:00pm
BioMarin looks to up pace of new drug filings
Sep 12, 2023 3:58pm
Roche axes hemophilia A gene therapy from pipeline
Jul 27, 2023 6:00am
FDA OKs companion Dx with BioMarin hemophilia gene therapy
Jun 30, 2023 10:35am
Novo Nordisk hemophilia hopeful can't shake Pfizer's shadow
Jun 27, 2023 4:00pm
Chasing Novo Nordisk, Pfizer reports phase 3 win in hemophilia
May 30, 2023 8:55am